BioHarvest Sciences Inc. Files November 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Nov 26, 2024

Sentiment: neutral

Topics: 6-K, foreign-issuer, regulatory-filing

TL;DR

BHSC filed a 6-K for Nov 2024, standard foreign issuer report.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on November 26, 2024, for the month of November 2024. The company, previously known as Midnight Star Ventures Corp. and CANNA-V-CELL SCIENCES INC., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. This filing is a report of a foreign private issuer.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s status as a foreign private issuer, which is relevant for investors tracking regulatory disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What were BioHarvest Sciences Inc.'s previous names?

BioHarvest Sciences Inc. was formerly known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices of BioHarvest Sciences Inc. are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Is BioHarvest Sciences Inc. filing an annual report on Form 20-F or 40-F?

BioHarvest Sciences Inc. indicates it files annual reports under cover of Form 20-F.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2024-11-25 17:37:23

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: November 25, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing